Biotin-modified bovine serum albumin nanoparticles as a potential drug delivery system for paclitaxel
Source abstract
Abstract
This study proposed a novel injectable nanocarrier for paclitaxel (PTX) based on biotin-modified bovine serum albumin (BSA). First, the biotin-modified BSA (biotin-BSA) was successfully synthesized and characterized by FT-IR analysis. Then, the PTX-loaded biotin-BSA nanoparticles (NPs) were prepared by disulfide bond reducing method and stabilized through the formation of intermolecular disulfide bonds. The influence of solution pH, glutathione concentration, temperature and organic solvent on the formation of NPs was studied. Under the optimized conditions, the PTX-loaded NPs had a mean diameter of 163 nm with zeta potential of − 35 mV. Transmission electron microscopy analysis showed that the NPs were sphere in shape and had a narrow size distribution. XRD and DSC spectra confirmed the successful encapsulation of PTX in the NPs in an amorphous state. The MTT assay verified that the in vitro cytotoxicity of PTX-loaded biotin-BSA NPs to biotin receptor-positive MCF-7 cells was a little higher than that of Taxol®. The cellular uptake experiments by flow cytometry demonstrated the biotin receptor-mediated endocytosis of biotin-BSA NPs. It can be concluded that the PTX-loaded biotin-BSA NPs were a promising drug delivery carrier for PTX.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Protein Interaction Studies and Fluorescence Analysis · Lanthanide and Transition Metal Complexes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Dian L, Hu Y, Lin J, Zhang J, Yan Y, Cui Y, Su Z, Lu W (2018) Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration. Int J Nanomed 13:719–73110.2147/IJN.S150140 ↗
2. Elzoghby AO, Samy WM, Elgindy NA (2012) Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 157(2):168–18210.1016/j.jconrel.2011.07.031 ↗
3. Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D, Noker P, Yao R, Labao E, Hawkins M, Soon-Shiong P (2006) Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res 12(4):1317–132410.1158/1078-0432.CCR-05-1634 ↗
4. Salehiabar M, Nosrati H, Javani E, Aliakbarzadeh F, Kheiri Manjili H, Davaran S, Danafar H (2018) Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery. Int J Biol Macromol 115:83–8910.1016/j.ijbiomac.2018.04.043 ↗
5. Crisante F, Francolini I, Bellusci M, Martinelli A, D’Ilario L, Piozzi A (2009) Antibiotic delivery polyurethanes containing albumin and polyallylamine nanoparticles. Eur J Pharm Sci 36(4):555–56410.1016/j.ejps.2008.12.006 ↗
6. Kushwah V, Katiyar SS, Dora CP, Kumar Agrawal A, Lamprou DA, Gupta RC, Jain S (2018) Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management. Acta Biomater 73:424–43610.1016/j.actbio.2018.03.057 ↗
7. Fürst W, Banerjee A (2005) Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity. Ann Thorac Surg 79(5):1522–152810.1016/j.athoracsur.2004.11.054 ↗
8. Wang W, Huang Y, Zhao S, Shao T, Cheng Y (2013) Human serum albumin (HSA) nanoparticles stabilized with intermolecular disulfide bonds. Chem Commun 49(22):2234–223610.1039/c3cc38397k ↗
9. Shi H, Cheng Q, Yuan S, Ding X, Liu Y (2015) Human serum albumin conjugated nanoparticles for pH and redox-responsive delivery of a prodrug of cisplatin. Chem Eur J 21(46):16547–1655410.1002/chem.201502756 ↗
10. Hong R, Han G, Fernández JM, B-j Kim, Forbes NS, Rotello VM (2006) Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J Am Chem Soc 128(4):1078–107910.1021/ja056726i ↗
11. Jiang L, Xu Y, Liu Q, Tang Y, Ge L, Zheng C, Zhu J, Liu J (2013) A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: formation dynamics, influencing factors and formation mechanisms investigation. Int J Pharm 443(1):80–8610.1016/j.ijpharm.2012.12.035 ↗
12. Gazzano E, Rolando B, Chegaev K, Salaroglio IC, Kopecka J, Pedrini I, Saponara S, Sorge M, Buondonno I, Stella B, Marengo A, Valoti M, Brancaccio M, Fruttero R, Gasco A, Arpicco S, Riganti C (2018) Folate-targeted liposomal nitrooxy-doxorubicin: an effective tool against P-glycoprotein-positive and folate receptor-positive tumors. J Control Release 270:37–5210.1016/j.jconrel.2017.11.042 ↗
13. Chen X, Sun H, Hu J, Han X, Liu H, Hu Y (2017) Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery. Colloid Surface B 152:77–8410.1016/j.colsurfb.2017.01.010 ↗
14. Alibakhshi A, Abarghooi Kahaki F, Ahangarzadeh S, Yaghoobi H, Yarian F, Arezumand R, Ranjbari J, Mokhtarzadeh A, de la Guardia M (2017) Targeted cancer therapy through antibody fragments-decorated nanomedicines. J Control Release 268:323–33410.1016/j.jconrel.2017.10.036 ↗
15. Kim SK, Foote MB, Huang L (2012) The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles. Biomaterials 33(15):3959–396610.1016/j.biomaterials.2012.02.010 ↗
16. Yang W, Wang M, Ma L, Li H, Huang L (2014) Synthesis and characterization of biotin modified cholesteryl pullulan as a novel anticancer drug carrier. Carbohyd Polym 99:720–72710.1016/j.carbpol.2013.09.013 ↗
17. Navid N, Navid G, Mohsen A, Fatemeh A, Reza KM, Rassoul D (2016) Biotin/folate-decorated human serum albumin nanoparticles of docetaxel: comparison of chemically conjugated nanostructures and physically loaded nanoparticles for targeting of breast cancer. Chem Biol Drug Des 87(1):69–8210.1111/cbdd.12624 ↗
18. Taheri A, Dinarvand R, Nouri FS, Khorramizadeh MR, Borougeni AT, Mansoori P, Atyabi F (2011) Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy. Int J Nanomed 6:1863–1874
19. Liang N, Sun S, Li X, Piao H, Piao H, Cui F, Fang L (2012) α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations. Int J Pharm 423(2):480–48810.1016/j.ijpharm.2011.12.004 ↗
20. Liu L, Bi Y, Zhou M, Chen X, He X, Zhang Y, Sun T, Ruan C, Chen Q, Wang H, Jiang C (2017) Biomimetic human serum albumin nanoparticle for efficiently targeting therapy to metastatic breast cancers. ACS Appl Mater Interfaces 9(8):7424–743510.1021/acsami.6b14390 ↗
21. Park C, Vo CL-N, Kang T, Oh E, Lee B-J (2015) New method and characterization of self-assembled gelatin-oleic nanoparticles using a desolvation method via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction. Eur J Pharm Biopharm 89:365–37310.1016/j.ejpb.2014.12.002 ↗
22. Bronze-Uhle ES, Costa BC, Ximenes VF, Lisboa-Filho PN (2017) Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanotechnol Sci Appl 10:11–2110.2147/NSA.S117018 ↗
23. Bourassa P, Hasni I, Tajmir-Riahi HA (2011) Folic acid complexes with human and bovine serum albumins. Food Chem 129(3):1148–115510.1016/j.foodchem.2011.05.094 ↗
24. Lin T, Zhao P, Jiang Y, Tang Y, Jin H, Pan Z, He H, Yang VC, Huang Y (2016) Blood–brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy. ACS Nano 10(11):9999–1001210.1021/acsnano.6b04268 ↗
25. Yang Z, Gong W, Wang Z, Li B, Li M, Xie X, Zhang H, Yang Y, Li Z, Li Y, Yu F, Mei X (2015) A novel drug-polyethylene glycol liquid compound method to prepare 10-hydroxycamptothecin loaded human serum albumin nanoparticle. Int J Pharm 490(1):412–42810.1016/j.ijpharm.2015.05.073 ↗
26. Kayani Z, Firuzi O, Bordbar A-K (2018) Doughnut-shaped bovine serum albumin nanoparticles loaded with doxorubicin for overcoming multidrug-resistant in cancer cells. Int J Biol Macromol 107:1835–184310.1016/j.ijbiomac.2017.10.041 ↗
27. Boonyaratanakornkit BB, Park CB, Clark DS (2002) Pressure effects on intra- and intermolecular interactions within proteins. Biochim Biophys Acta 1595(1):235–24910.1016/S0167-4838(01)00347-8 ↗
28. Grossmann L, Ebert S, Hinrichs J, Weiss J (2018) Effect of precipitation, lyophilization, and organic solvent extraction on preparation of protein-rich powders from the microalgae Chlorella protothecoides. Algal Res 29:266–27610.1016/j.algal.2017.11.019 ↗
29. Albanese A, Tang PS, Chan WCW (2012) The Effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14(1):1–1610.1146/annurev-bioeng-071811-150124 ↗
30. Prabha G, Raj V (2017) Sodium alginate–polyvinyl alcohol–bovin serum albumin coated Fe3O4 nanoparticles as anticancer drug delivery vehicle: doxorubicin loading and in vitro release study and cytotoxicity to HepG2 and L02 cells. Mater Sci Eng C Mater Biol Appl 79:410–42210.1016/j.msec.2017.04.075 ↗
31. Kim C, Lee SC, Kang SW, Kwon IC, Kim Y-H, Jeong SY (2000) Synthesis and the micellar characteristics of poly(ethylene oxide)-deoxycholic acid conjugates. Langmuir 16(11):4792–479710.1021/la9907634 ↗
32. Ren WX, Han J, Uhm S, Jang YJ, Kang C, Kim J-H, Kim JS (2015) Recent development of biotin conjugation in biological imaging, sensing, and target delivery. Chem Commun 51(52):10403–1041810.1039/C5CC03075G ↗